Don't Overlook Bruker (BRKR) International Revenue Trends While Assessing the StockZacks Investment Research • 02/18/26
Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QCBusiness Wire • 02/09/26
Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI OrchestrationBusiness Wire • 02/09/26
Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and WebcastBusiness Wire • 02/05/26
Bruker Corporation (BRKR) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/12/26
Bruker Announces $500 Million in Multi-Year Orders from Two Global Healthcare Companies for Supply of High-Performance Superconductors for MRIBusiness Wire • 01/09/26
Bruker Consolidates Ownership of TOFWERK in Expansion of Mass Spectrometry Portfolio into New Applied MarketsBusiness Wire • 01/08/26
RI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI)Business Wire • 12/22/25
Bruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European InstitutionsBusiness Wire • 12/10/25
Bruker Corporation (BRKR) Presents at 53rd Annual Nasdaq Investor Conference TranscriptSeeking Alpha • 12/10/25
Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026Business Wire • 12/08/25
Bruker (BRKR) Up 17.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/03/25